The chronic kidney disease-bone and mineral disorders (CKD-MBD) represents a dinamic area of research. Recently, new factors such as FGF-23 have been added to the classic list of regulators of bone metabolism, which include calcium, phosphorus, PTH and calcitriol. Vascular calcification, one of the most important complication of CKD-MBD is regulated by a complex variety of promoters and inhibitors. The relationship between vascular calcification, bone loss and mortality, together with the existence of likely common signaling pathways are subject of interesting investigations
Progressive loss of kidney function leads to reduced production of calcitriol (1,25-dihydroxyvitamin...
Resumen: Osteoporosis (OP) y enfermedad renal crónica (ERC) influyen de manera independiente en la s...
Progressive loss of kidney function leads to reduced production of calcitriol (1,25-dihydroxyvitamin...
The chronic kidney disease-bone and mineral disorders (CKD-MBD) represents a dinamic area of researc...
ResumenLas alteraciones del metabolismo mineral y óseo se inician tempranamente en el desarrollo de ...
ResumenUna de las principales causas de morbimortalidad en el paciente con enfermedad renal crónica ...
AbstractCardiovascular factors are one of the main causes of morbidity and mortality in patients wit...
In patients with progressive chronic kidney disease (CKD), the homeostatic mechanisms regulating ca...
There is a clinic and epidemiological evidence suggesting that impaired bone turnover is associated ...
Background: chronic kidney disease (CKD) is a public health problem, and bone mineral metabolism dis...
Introduction: In cases of chronic kidney disease (CKD), bone and mineral metabolism changes occur wh...
La enfermedad mineral ósea (EMO) es un término amplio que incluye a las alteraciones séricas del cal...
RESUMEN: Los pacientes con enfermedad renal crónica (ERC) están sometidos a una serie de factores de...
INTRODUÇÃO: Os níveis séricos de fósforo (P) têm sido associados a doenças cardiovasculares e mortal...
La homeostasis del calcio (Ca2+) y del fosfato (PO4 3- ) está coordinada por factores sistémicos y l...
Progressive loss of kidney function leads to reduced production of calcitriol (1,25-dihydroxyvitamin...
Resumen: Osteoporosis (OP) y enfermedad renal crónica (ERC) influyen de manera independiente en la s...
Progressive loss of kidney function leads to reduced production of calcitriol (1,25-dihydroxyvitamin...
The chronic kidney disease-bone and mineral disorders (CKD-MBD) represents a dinamic area of researc...
ResumenLas alteraciones del metabolismo mineral y óseo se inician tempranamente en el desarrollo de ...
ResumenUna de las principales causas de morbimortalidad en el paciente con enfermedad renal crónica ...
AbstractCardiovascular factors are one of the main causes of morbidity and mortality in patients wit...
In patients with progressive chronic kidney disease (CKD), the homeostatic mechanisms regulating ca...
There is a clinic and epidemiological evidence suggesting that impaired bone turnover is associated ...
Background: chronic kidney disease (CKD) is a public health problem, and bone mineral metabolism dis...
Introduction: In cases of chronic kidney disease (CKD), bone and mineral metabolism changes occur wh...
La enfermedad mineral ósea (EMO) es un término amplio que incluye a las alteraciones séricas del cal...
RESUMEN: Los pacientes con enfermedad renal crónica (ERC) están sometidos a una serie de factores de...
INTRODUÇÃO: Os níveis séricos de fósforo (P) têm sido associados a doenças cardiovasculares e mortal...
La homeostasis del calcio (Ca2+) y del fosfato (PO4 3- ) está coordinada por factores sistémicos y l...
Progressive loss of kidney function leads to reduced production of calcitriol (1,25-dihydroxyvitamin...
Resumen: Osteoporosis (OP) y enfermedad renal crónica (ERC) influyen de manera independiente en la s...
Progressive loss of kidney function leads to reduced production of calcitriol (1,25-dihydroxyvitamin...